Interpace Diagnostics Group, Inc. (IDXG) financial statements (2021 and earlier)

Company profile

Business Address MORRIS CORPORATE CENTER 1,
PARSIPPANY, NJ 07054
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5261518
Cash and cash equivalents5261518
Short-term investments     0
Receivables810932 
Inventory, net of allowances, customer advances and progress billings22    
Inventory22    
Prepaid expense     0
Disposal group, including discontinued operation     5
Other current assets442113
Other undisclosed current assets(2)(2)  03
Total current assets:18171820419
Noncurrent Assets
Operating lease, right-of-use asset5 
Property, plant and equipment771111
Intangible assets, net (including goodwill)212430333643
Goodwill88    
Intangible assets, net (excluding goodwill)131630333643
Disposal group, including discontinued operation, noncurrent assets    00
Other noncurrent assets000003
Other undisclosed noncurrent assets 4  (0) 
Total noncurrent assets:333531343849
TOTAL ASSETS:515248544268
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities58871210
Accounts payable351022
Accrued liabilities005566
Employee-related liabilities121142
Taxes payable00    
Deferred revenue00
Debt12   1
Due to related parties 1    
Disposal group, including discontinued operation1111412
Business combination, contingent consideration, liability11    
Other undisclosed current liabilities86    
Total current liabilities:1617881623
Noncurrent Liabilities
Long-term debt and lease obligation43  8 
Long-term debt, excluding current maturities    8 
Finance lease, liability00
Operating lease, liability43
Liabilities, other than long-term debt, including:754446
Deferred revenue and credits  0
Liability for uncertainty in income taxes  4443
Regulatory liability    03
Other liabilities4500 0
Business combination, contingent consideration, liability2     
Other undisclosed liabilities, other than long-term debt   0  
Other undisclosed noncurrent liabilities(0)5017 
Total noncurrent liabilities:101346196
Other undisclosed liabilities  3  25
Total liabilities:263016143555
Temporary equity, carrying amount 26    
Stockholders' equity
Stockholders' equity attributable to parent, including:(22)(4)3340713
Common stock00000 
Treasury stock, value(2)(2)(2)(2)(2)(8)
Additional paid in capital184183176173128133
Accumulated other comprehensive income     0
Accumulated deficit(204)(186)(141)(132)(120)(111)
Other undisclosed stockholders' equity attributable to parent     0
Other undisclosed stockholders' equity47     
Total stockholders' equity:25(4)3340713
TOTAL LIABILITIES AND EQUITY:515248544268

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues28242216139
Revenue, net16139
Cost of revenue(19)(16)(10)(7)(7)(7)
Cost of goods and services sold  (10)   
Gross profit:9812963
Operating expenses(33)(35)(24)(15)(13)(43)
Operating loss:(24)(26)(12)(6)(6)(40)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
100(2)0(0)
Interest and debt expense(1)(0)(0)(5)(2)(0)
Loss from continuing operations before equity method investments, income taxes:(23)(27)(12)(13)(9)(41)
Other undisclosed loss from continuing operations before income taxes     (3)
Loss from continuing operations before income taxes:(23)(27)(12)(13)(9)(44)
Income tax expense (benefit)(0)0(0)0013
Loss from continuing operations:(23)(27)(12)(13)(8)(31)
Income (loss) from discontinued operations(0)(0)01020
Net loss attributable to parent:(24)(27)(12)(12)(8)(11)
Preferred stock dividends and other adjustments3(0)    
Other undisclosed net loss available to common stockholders, basic(6)     
Net loss available to common stockholders, diluted:(27)(27)(12)(12)(8)(11)

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(24)(27)(12)(12)(8)(11)
Comprehensive loss:(24)(27)(12)(12)(8)(11)
Other undisclosed comprehensive loss, net of tax, attributable to parent     (0)
Comprehensive loss, net of tax, attributable to parent:(24)(27)(12)(12)(8)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: